(2R)-4-(6-(Azetidin-3-ylbuta-1,3-diyn-1-yl)-3-oxo-1H-pyrrolo[1,2-c]imidazol-2(3H)-yl)-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide

ID: ALA4468537

Chembl Id: CHEMBL4468537

PubChem CID: 155533263

Max Phase: Preclinical

Molecular Formula: C19H22N4O5S

Molecular Weight: 418.48

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  C[C@@](CCN1Cc2cc(C#CC#CC3CNC3)cn2C1=O)(C(=O)NO)S(C)(=O)=O

Standard InChI:  InChI=1S/C19H22N4O5S/c1-19(17(24)21-26,29(2,27)28)7-8-22-13-16-9-14(12-23(16)18(22)25)5-3-4-6-15-10-20-11-15/h9,12,15,20,26H,7-8,10-11,13H2,1-2H3,(H,21,24)/t19-/m1/s1

Standard InChI Key:  VYQDZTOCUMYPNV-LJQANCHMSA-N

Alternative Forms

1. Parent:

   

   ALA4468537

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 418.48

Molecular Weight (Monoisotopic): 418.1311

AlogP: -0.46

#Rotatable Bonds: 5

Polar Surface Area: 120.74

Molecular Species: BASE

HBA: 7

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.60

CX Basic pKa: 9.50

CX LogP: -2.14

CX LogD: -3.11

Aromatic Rings: 1

Heavy Atoms: 29

QED Weighted: 0.34

Np Likeness Score: 0.02

References

1. Panchaud P, Surivet JP, Diethelm S, Blumstein AC, Gauvin JC, Jacob L, Masse F, Mathieu G, Mirre A, Schmitt C, Enderlin-Paput M, Lange R, Gnerre C, Seeland S, Herrmann C, Locher HH, Seiler P, Ritz D, Rueedi G..  (2020)  Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous Administration.,  63  (1): [PMID:31804829] [10.1021/acs.jmedchem.9b01605]

Source

Source(1):

• Scientific Literature